SIRT MAA Mapping — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — To assess the hepatopulmonary shunt fraction — if >20% of injected microspheres bypass the liver to the lungs, SIRT is contraindicated due to radiation pneumonitis risk; the mapping also identifies aberrant vessels feeding the GI tract
Pre-SIRT mapping angiography with Tc-99m MAA simulates microsphere distribution: (1) assesses hepatopulmonary shunt fraction — if >20%, significant lung irradiation would occur (contraindication); 10-20% requires dose reduction. (2) Identifies aberrant vessels from the hepatic artery to GI organs (stomach, duodenum, gallbladder) that could cause non-target radiation damage (requires coil embolisation before SIRT). (3) Confirms adequate tumour targeting. This is a mandatory safety assessment before every SIRT procedure.
Reference: NICE IPG401; ESMO mCRC; Comprehensive SIRT guidelines